In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.- Contains 16 relevant, practice-oriented topics including COVID-19 and emerging lung infections in the immunocompromised patient; pulmonary immunocompromise in stem cell transplantation and cellular therapy; pulmonary immunocompromise in solid organ transplantation; pulmonary immunocompromise in chronic and high dose steroid therapy; and more- Provides in-depth clinical reviews on pulmonary disease in the immunocompromised host, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Algorithmic Approach to an Abnormal Computed Tomography of the Chest in the Immunocompromised HostVaccines and Other Preventative Strategies for Immunocompromised Pneumonia
Host-Directed Adjunctive Therapies in Immunocompromised Patients with Pneumonia
Sequelae of Immunocompromised Host Pneumonia
Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection
The Microbiome and Pulmonary Immune Function
Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia
Acute Lung Injury in Immunocompromised Patients
Pulmonary Complications in Hematologic Malignancies
Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy
Pulmonary Immunocompromise in Solid Organ Transplantation
Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy
Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases
Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease
Coronavirus Disease 2019 and Emerging Lung Infections in the Immunocompromised Patient
Authors
Scott Evans The University of Texas MD Anderson CancerCenter,
Department of Pulmonary Medicine
Houston, TX, USA. Guang-Shing Cheng Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington, Seattle, Washington, USA. Julio Alberto Ramirez Professor of Medicine Chief, Division of Infectious
Diseases,
University of Louisville
Louisville, KY. Bashar Staitieh Assistant Professor of Medicine, Emory University
School of Medicine.
